Hippocratic AI builds and deploys the safest generative AI agents for healthcare. Their platform powers clinical conversational agents (over 1,000+ specialized AI agents) used across providers, payors, pharma, and life sciences to automate patient outreach, intake, care management, and trial support while prioritizing clinical safety and escalation to human clinicians.

The company develops Polaris (latest: Polaris 5.0), a medically focused LLM architecture trained on more than 180 million de-identified clinical interactions and clinically validated by thousands of licensed clinicians. Hippocratic AI emphasizes safety-first design, clinical validation, and human escalation pathways so agents do not diagnose or prescribe but support workflows such as readmission prevention, vaccination outreach, RPM adherence, intake, scheduling, adverse event detection, and RWE data collection.

Core offerings include configurable AI healthcare agents, research and safety benchmarking, and integrations for call center and clinical workflows to increase clinical capacity, improve quality outcomes, and reduce costs.

Hippocratic AI has raised significant venture funding (reported total raised: $404 million) from investors including General Catalyst, CapitalG, a16z BioHealth and others. Customers report measurable outcomes such as reduced readmissions, higher screening and vaccination rates, and substantial ROI from deployment.

For partnerships, careers, and detailed safety/research materials, see the company website and published case studies.